The prime-boost strategy: exciting prospects for improved vaccination

被引：291

作者：

Ramshaw, IA ^{[1
]}

Ramsay, AJ

机构：

[1] Australian Natl Univ, John Curtin Sch Med Res, Div Cell Biol & Immunol, Canberra, ACT 2601, Australia

[2] Univ Newcastle, Fac Med, Ctr Biomol Vaccine Technol, Discipline Immunol & Microbiol, Newcastle, NSW 2300, Australia

来源：

IMMUNOLOGY TODAY | 2000年 / 21卷 / 04期

关键词：

D O I：

10.1016/S0167-5699(00)01612-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Unprecedented levels of cell-mediated immunity can be stimulated by the consecutive use of DNA vaccines and attenuated poxvirus vectors encoding similar heterologous antigens. This may offer a means of preventive vaccination against diseases for which no effective treatment is available.

引用

收藏

页码：163 / 165

页数：3

相关论文

共 20 条

[1]

ALLEN TM, 1999, 17 ANN S NONH PRIM M

[2] T lymphocyte responses in HIV-1 infection: implications for vaccine development [J].

Brander, C ;

Walker, B .

CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (04) :451-459

[3] T cell affinity maturation by selective expansion during infection [J].

Busch, DH ;

Pamer, EG .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) :701-709

[4] Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line [J].

Carroll, MW ;

Moss, B .

VIROLOGY, 1997, 238 (02) :198-211

[5] DNA vaccines [J].

Donnelly, JJ ;

Ulmer, JB ;

Shiver, JW ;

Liu, MA .

ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648

[6]

Excler JL, 1997, AIDS, V11, pS127

[7] Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen [J].

Hanke, T ;

Samuel, RV ;

Blanchard, TJ ;

Neumann, VC ;

Allen, TM ;

Boyson, JE ;

Sharpe, SA ;

Cook, N ;

Smith, GL ;

Watkins, DI ;

Cranage, MP ;

McMichael, AJ .

JOURNAL OF VIROLOGY, 1999, 73 (09) :7524-7532

[8] Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus [J].

Kent, SJ ;

Zhao, A ;

Best, SJ ;

Chandler, JD ;

Boyle, DB ;

Ramshaw, IA .

JOURNAL OF VIROLOGY, 1998, 72 (12) :10180-10188

[9]

LEONG KH, 1995, VACCINES, P327

[10] Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA pins protein vaccination [J].

Letvin, NL ;

Montefiori, DC ;

Yasutomi, Y ;

Perry, HC ;

Davies, ME ;

Lekutis, C ;

Alroy, M ;

Freed, DC ;

Lord, CI ;

Handt, LK ;

Liu, MA ;

Shiver, JW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9378-9383